Evolution of the Average Target: UGI Corporation

Evolution of the Target Price: UGI Corporation

Changes in Analyst Recommendations: UGI Corporation

958.Ah348ad6ZE98uIv-kEc0QexDfM1_zGrr1MkcxLpzy48.a1KhwJQcKSga-s7PpClFEpgyFZoSlTC8pZtdp9sr_u0yZcnJ0BY0KkqL7A~d39c2fc11f72e21d31426a9aab3845f0
29/09 Scotiabank Initiates UGI at Sector Outperform With $46 Price Target MT
14/09 Huntington Capital Initiates UGI at Outperform With $54 Price Target MT
10/09 UGI Shares Rise After Jefferies Upgrade MT
09/09 Jefferies Upgrades UGI to Buy From Hold, Adjusts Price Target to $43 From $40 MT
15/24/15 Mizuho Upgrades UGI to Outperform From Neutral, Adjusts Price Target to $30 From $27 MT
17/24/17 Mizuho Raises Price Target on UGI to $27 From $26, Keeps Neutral Rating MT
14/24/14 Wells Fargo Downgrades UGI to Equalweight From Overweight, Adjusts Price Target to $28 From $27 MT
18/24/18 Mizuho Adjusts UGI's Price Target to $26 From $29, Keeps Neutral Rating MT
11/23/11 Mizuho Securities Adjusts UGI Price Target to $29 From $33, Maintains Neutral Rating MT
28/23/28 Wells Fargo Upgrades UGI to Overweight From Equalweight, Trims Price Target to $27 From $28 MT
04/23/04 Wells Fargo Adjusts Price Target on UGI to $28 From $35, Maintains Equal-Weight Rating MT
18/23/18 Barclays Adjusts Price Target on UGI to $37 From $40, Maintains Underweight Rating MT
02/23/02 Barclays Adjusts Price Target on UGI to $40 From $39, Maintains Underweight Rating MT
18/23/18 Barclays Downgrades UGI to Underweight From Equalweight, Price Target is $39 MT
18/23/18 Analyst recommendations: Adobe, AstraZeneca, Morgan Stanley, Oracle... Zonebourse
10/23/10 Wells Fargo Adjusts Price Target on UGI to $42 From $41, Maintains Equal-Weight Rating MT
23/22/23 BofA Securities Downgrades UGI to Underperform From Neutral, Adjusts Price Target to $41 From $43 MT
21/22/21 Wells Fargo Adjusts Price Target on UGI to $39 From $36, Maintains Equal-Weight Rating MT
19/22/19 Barclays Trims UGI's Price Target to $36 From $40, Maintains Equalweight Rating MT
19/22/19 Wells Fargo Adjusts UGI's Price Target to $36 From $42, Reiterates Equalweight Rating MT
19/22/19 Barclays Adjusts UGI's Price Target to $36 From $40, Keeps Equalweight Rating MT
08/22/08 Wells Fargo Raises UGI's Price Target to $42 From $41, Maintains Equalweight Rating MT
29/22/29 Wells Fargo Adjusts UGI's Price Target to $40 from $46, Keeps Equalweight Rating MT
27/22/27 Janney Lowers Fair Value on UGI to $60 From $64, Maintains Buy Rating MT
22/22/22 Barclays Adjusts UGI's Price Target to $40 From $45, Keeps Equalweight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+16.26%
+4.22%
+17.71%
+9.3%
+13.8%
- +5.92%
+12.89%
-8.48%
Average +8.95%
Weighted average by Cap. +9.37%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
37.20USD
Average target price
43.25USD
Spread / Average Target
+16.26%
High Price Target
46.00USD
Spread / Highest target
+23.66%
Low Price Target
42.00USD
Spread / Lowest Target
+12.90%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
  1. Stock Market
  2. Stocks
  3. UGI Stock
  4. Consensus UGI Corporation